Iovance Biotherapeutics (IOVA) Shares Issued (2016 - 2025)
Historic Shares Issued for Iovance Biotherapeutics (IOVA) over the last 11 years, with Q3 2025 value amounting to $88.5 million.
- Iovance Biotherapeutics' Shares Issued rose 8628.73% to $88.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $250.5 million, marking a year-over-year decrease of 3694.29%. This contributed to the annual value of $397.3 million for FY2024, which is 1424.12% down from last year.
- Per Iovance Biotherapeutics' latest filing, its Shares Issued stood at $88.5 million for Q3 2025, which was up 8628.73% from $13.1 million recorded in Q2 2025.
- Iovance Biotherapeutics' Shares Issued's 5-year high stood at $260.1 million during Q1 2023, with a 5-year trough of $1000.0 in Q4 2023.
- Over the past 3 years, Iovance Biotherapeutics' median Shares Issued value was $148.9 million (recorded in 2025), while the average stood at $123.5 million.
- Data for Iovance Biotherapeutics' Shares Issued shows a peak YoY increase of 8628.73% (in 2025) and a maximum YoY decrease of 9139.74% (in 2025) over the last 5 years.
- Iovance Biotherapeutics' Shares Issued (Quarter) stood at $1000.0 in 2023, then skyrocketed by 4751700.0% to $47.5 million in 2024, then surged by 86.29% to $88.5 million in 2025.
- Its Shares Issued stands at $88.5 million for Q3 2025, versus $13.1 million for Q2 2025 and $148.9 million for Q1 2025.